Ksenia Pochigaeva

Ksenia Pochigaeva

Auto-generated profile, based on publicly available information

Ksenia Pochigaeva

Moscow Research and Clinical Center for Neuropsychiatry

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
Edor KabashiEdor Kabashi
Edor Kabashi
Paul ValdmanisPaul Valdmanis
Paul Valdmanis
PDPatrick Dion
Patrick Dion
DSDan Spiegelman
Dan Spiegelman
BMBrendan J McConkey
Brendan J McConkey
GRGuy A Rouleau
Guy A Rouleau

7 January 2017 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
KPKsenia Pochigaeva
Ksenia Pochigaeva
TDTatiana Druzhkova
Tatiana Druzhkova
AYAlexander Yakovlev
Alexander Yakovlev
MOMikhail Onufriev
Mikhail Onufriev
MGMaria Grishkina
Maria Grishkina
Natalia V. GulyaevaNatalia V. Gulyaeva
Natalia V. Gulyaeva

1 June 2009 in Archives of Neurology
Verified
Journal Article
Closed access
PDF file
PGPaul H. Gordon
Paul H. Gordon
PCPhilippe Corcia
Philippe Corcia
LLLucette Lacomblez
Lucette Lacomblez
KPKsenia Pochigaeva
Ksenia Pochigaeva
JAJean-Louis Abitbol
Jean-Louis Abitbol
VMVincent Meininger
Vincent Meininger
Research from JAMA Neurology — Defining Survival as an Outcome Measure in Amyotrophic Lateral Sclerosis

18 December 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
TDTatiana Druzhkova
Tatiana Druzhkova
KPKsenia Pochigaeva
Ksenia Pochigaeva
AYAlexander Yakovlev
Alexander Yakovlev
EKEvdokia Kazimirova
Evdokia Kazimirova
MGMaria Grishkina
Maria Grishkina
Natalia V. GulyaevaNatalia V. Gulyaeva
Natalia V. Gulyaeva

15 April 2021 in Epilepsia
Verified
Journal Article
Closed access
PDF file
MZMikhail Zinchuk
Mikhail Zinchuk
GKGeorgii Kustov
Georgii Kustov
EPEvgenii Pashnin
Evgenii Pashnin
KPKsenia Pochigaeva
Ksenia Pochigaeva
FRFlora Rider
Flora Rider
AGAlla Guekht
Alla Guekht

1 April 2015 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
SFS. V. Freiman
S. V. Freiman
MOM. V. Onufriev
M. V. Onufriev
TDT. A. Druzhkova
T. A. Druzhkova
AYAlexander Yakovlev
Alexander Yakovlev
KPK. I. Pochigaeva
K. I. Pochigaeva
Natalia V. GulyaevaNatalia V. Gulyaeva
Natalia V. Gulyaeva
Anxiety and depression are the most common mental pathologies. Actual stress reactivity is an important parameter that characterizes the current state of a patient and, potentially, their prognosis and treatment efficiency. It is an important task to find simple tests for the assessment of stress reactivity, which may be used in clinical practice. We present the results of our pilot study of stress-reactivity markers in patients with anxiety and depression (ADS) symptoms. The blood of patients was analyzed before and after an emotional stress test. The results were compared with the data from experiments on rats with depression-like behavior that also were exposed to stress. The glucose blood level significantly increased in patients with ADS and rats with depression-like behavior after the stress test. This change in glucose level was absent in healthy people and control rats. Therefore, moderate stress with an analysis of the glucose blood level is a valid approach for the evaluation of stress reactivity, both in clinical and experimental models.